Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.

Publikation

Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study.

Wissenschaftlicher Artikel/Review - 25.07.2024

Fleischmann Roy, Meerwein Sebastian, Charles-Schoeman Christina, Combe Bernard, Hall Stephen, Khan Nasser, Carter Kyle M, Camp Heidi S, Rubbert-Roth Andrea

Fleischmann, Roy

Meerwein, Sebastian

Charles-Schoeman, Christina

Combe, Bernard

Hall, Stephen

Khan, Nasser

Carter, Kyle M

Camp, Heidi S

Rubbert-Roth, Andrea

Rheumatologie · Dept. I